Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/18/2025

NIV Indications and Management in Myasthenia Gravis

Primary Indications for NIV

  • NIV is indicated for acute or acute-on-chronic hypercapnic respiratory failure due to neuromuscular disease, including myasthenia gravis, as recommended by the European Respiratory Society 1

Predictors of NIV Success and Contraindications

  • Absence of severe bulbar dysfunction is critical for NIV success, as bulbar dysfunction makes NIV delivery difficult or impossible and increases failure risk, according to the British Thoracic Society 2
  • Severe bulbar dysfunction is a contraindication for NIV, as it makes NIV delivery impossible and significantly increases aspiration risk, as stated by the British Thoracic Society 2
  • Copious respiratory secretions that cannot be adequately cleared are a contraindication for NIV, as recommended by the European Respiratory Society 1
  • Deteriorating consciousness level requires immediate consideration of intubation, as advised by the American Thoracic Society 3

Initial NIV Settings and Interface Selection

  • Patients with neuromuscular disease typically require low levels of pressure support compared to other conditions, according to the British Thoracic Society 2
  • A full-face mask should be used initially in the acute setting, transitioning to nasal mask after 24 hours as the patient improves, as recommended by the European Respiratory Society 1 and the American Thoracic Society 3

Monitoring and Assessment of Response

  • Difficulty achieving adequate oxygenation or rapid desaturation during NIV breaks are important warning signs of deterioration in neuromuscular disease, as stated by the British Thoracic Society 2
  • Senior staff should be involved in decision-making, particularly when experience with neuromuscular disease is limited, as advised by the British Thoracic Society 2

Critical Pitfalls to Avoid

  • Do not underestimate the impact of bulbar dysfunction, as communication difficulties and aspiration risk make NIV delivery extremely challenging, as stated by the British Thoracic Society 2
  • Anticipate sudden deterioration in neuromuscular disease patients, as decline can be very rapid, as advised by the British Thoracic Society 2
  • Do not use NIV as a substitute for intubation when invasive ventilation is clearly more appropriate, particularly in patients with severe bulbar dysfunction or hypercapnia, as recommended by the European Respiratory Society 1

Extubation Considerations

  • Upper airway patency and bulbar function must be carefully evaluated prior to extubation, as stated by the British Thoracic Society 2